University of Kufa Official Website for the University of Kufa
Faculty of Pharmacy – University of Kufa held a symposium”The Therapeutic Effect of Pembrolizumab in Triple-Negative Breast Cancer”.
It included the effectiveness of treatment compared to a placebo, and evaluation of the treatment’s side effects and the possibility of controlling them.
It aimed to compare and evaluate the therapeutic effect of pembrolizumab, to determine the extent of response and the duration of survival without symptoms or progression of breast cancer cells.
It concluded that most patients with triple-negative breast cancer suffer from poor response to chemotherapy, high mortality rates, and a high rate of recurrence after recovery. The addition of pembrolizumab treatment to patients with triple-negative breast cancer led to an increase in the survival rate of patients and an increase in response rates.
